The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone | Zendy

Mette Petri Lauritsen | Zendy; J. G. Bentzen | Zendy; Anja Pinborg | Zendy; Anne Loft | Zendy; Julie Lyng Forman | Zendy; Lea Langhoff Thuesen | Zendy; Arieh S. Cohen | Zendy; David M. Hougaard | Zendy; Anders Nyboe Andersen | Zendy

Open Access

The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone

Author(s) -

Mette Petri Lauritsen,

J. G. Bentzen,

Anja Pinborg,

Anne Loft,

Julie Lyng Forman,

Lea Langhoff Thuesen,

Arieh S. Cohen,

David M. Hougaard,

Anders Nyboe Andersen

Publication year - 2014

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/det469

Subject(s) - polycystic ovary , anti müllerian hormone , hyperandrogenism , anovulation , hirsutism , gynecology , medicine , antral follicle , population , menstrual cycle , rotterdam study , obstetrics , prospective cohort study , hormone , insulin resistance , insulin , environmental health

What is the prevalence in a normal population of polycystic ovary syndrome (PCOS) according to the Rotterdam criteria versus revised criteria including anti-Müllerian hormone (AMH)?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research